Amyloid beta (Aβ) peptides are the major components of senile
plaques, one of the main pathological hallmarks of Alzheimer disease (AD).
However, Aβ peptides’ functions are not fully understood and
seem to be highly pleiotropic. We hypothesized that plasma Aβ peptides
concentrations could be a suitable endophenotype for a genome-wide association
study (GWAS) designed to (i) identify novel genetic factors involved in amyloid
precursor protein metabolism and (ii) highlight relevant Aβ-related
physiological and pathophysiological processes. Hence, we performed a
genome-wide association meta-analysis of four studies totaling 3 528 healthy
individuals of European descent and for whom plasma
Aβ1–40 and Aβ1–42
peptides levels had been quantified. Although we did not observe any genome-wide
significant locus, we identified 18 suggestive loci (P<1
× 10−5). Enrichment-pathway analyses revealed
canonical pathways mainly involved in neuronal functions, for example, axonal
guidance signaling. We also assessed the biological impact of the gene most
strongly associated with plasma Aβ1–42 levels
(cortexin 3, CTXN3) on APP metabolism in vitro and found that
the gene protein was able to modulate Aβ1–42
secretion. In conclusion, our study results suggest that plasma Aβ
peptides levels are valid endophenotypes in GWASs and can be used to
characterize the metabolism and functions of APP and its metabolites.